NCT07552116

Brief Summary

Objective: The aim of this study was to detect the impact of low intensity laser therapy on immune system response among DS children with pneumonia. Material and Methods: Forty DS children with bronchopneumonia, were included into ; group (A) received low intensity laser therapy, inspiratory muscle training in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Apr 2026May 2026

Study Start

First participant enrolled

April 6, 2026

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 27, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2026

Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 15, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

Laser, Immune, Pneumonia, Dawn syndrome

Outcome Measures

Primary Outcomes (4)

  • IgG

    Immunoglobulin-G (mg/dl)

    at baseline and after one month

  • IgA

    Immunoglobulin-A(mg/dl)

    at baseline and after one month

  • IgM

    Immunoglobulin-M (mg/dl)

    at baseline and after one month

  • WBCs

    White blood cells (thousands/mm3)

    at baseline and after one month

Secondary Outcomes (2)

  • RR

    at baseline and after one month

  • SaO2

    at baseline and after one month

Study Arms (2)

group (A)

EXPERIMENTAL

received low intensity laser therapy, inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment at a frequency of 3 sessions per week for one month

Other: low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. MeasurementsOther: received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.

group (B)

EXPERIMENTAL

received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.

Other: received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.

Interventions

low intensity laser therapy ,muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements

Also known as: low intensity laser therapy, muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements
group (A)

received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.

Also known as: inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment.
group (A)group (B)

Eligibility Criteria

Age3 Years - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Dawn Syndrome children with pneumonia
  • Mean age of 3.73±1.82 year
  • Children were in the first attack of bronchopneumonia.

You may not qualify if:

  • Other chest disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mona Mohamed Abdelkhalek

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Pneumonia

Interventions

Drainage, Postural

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

DrainageTherapeuticsPhysical Therapy ModalitiesRehabilitationRespiratory Therapy

Study Officials

  • Mona Mohamed Abdelkhalek, assistance prof

    Badr University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mona Mohamed Abdelkhalek, assistance professor

CONTACT

Mona Mohamed Abdelkhalek, assistance professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Forty DS children with bronchopneumonia, mean age of 3.73±1.82 year and were included into 2 equal groups; group (A) received low intensity laser therapy, inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment at a frequency of 3 sessions per week for one month, where the second group (B) received inspiratory muscle training using incentive spirometer associated with postural drainage in addition to medical treatment. Measurements of WBCs, IgG, IgA, IgM, RR and SaO2 were obtained for both groups before treatment and after one month at the end of the treatment program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistance professor

Study Record Dates

First Submitted

April 15, 2026

First Posted

April 27, 2026

Study Start

April 6, 2026

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

May 30, 2026

Last Updated

April 27, 2026

Record last verified: 2026-04

Locations